A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies (CaDAnCe-101)
NCT 05006716 Brief Summary Study consists of two main parts to explore…
Read more arrow_forwardNCT 05006716 Brief Summary Study consists of two main parts to explore…
Read more arrow_forwardNCT 05999994 Brief Summary The main purpose of the master is to…
Read more arrow_forwardNCT 06528301 Brief Summary This study is a Phase 1 dose-escalation and…
Read more arrow_forwardNCT 04923048 Brief Summary This is a Phase 1/2 study of GB261…
Read more arrow_forwardNCT 04923048 Brief Summary This is a Phase 1/2 study of GB261…
Read more arrow_forwardNCT 04594642 Brief Summary This phase 1 study will investigate the safety,…
Read more arrow_forwardNCT 06564038 Brief Summary The purpose of this study is to assess…
Read more arrow_forwardNCT 05279300 Brief Summary This is a first-in-human (FIH) study to evaluate…
Read more arrow_forwardNCT 06392477 Brief Summary This is a multicenter, multiple expansion cohort, Phase…
Read more arrow_forwardNCT 06139406 Brief Summary The purpose of this study is to…
Read more arrow_forward